1983-2022

Almost 40 years of enthusiastic service to health and to life.

A family, an ambition and an international success story

2022

Panpharma opens a representative office in Vietnam.

2021

Panpharma invests to modernise, secure and increase beta-lactam production capacity at its Luitré site in Brittany.

Launch of the MittlestandSanté Club, bringing together 7 leaders of French and German family-owned industrial health companies, including Marie-Hélène Dick, who represents Panpharma.

The 2021 Woman of Industry award was awarded to Marie-Hélène Dick.

2020

COVID Health Crisis: Panpharma teams helped the health authorities during the pandemic to build a strategic stock of critical anaesthetics to supply European hospitals.

2018

ISO 26000. Panpharma’s CSR (Corporate Social Responsibility) label, Confirmed Level

2017

Founding of Panpharma Nordic.

2015

A new testing laboratory is built at Luitré and Panpharma UK is created

2012

Marie-Hélène Dick, Company Chair of Panpharma, is awarded the EY prize for entrepreneur of the year, Western region.

Development of hospital activity in Germany.

2008

Launch of the first ready-to-use pocket paracetamol (patented product)

2002

Acquisition of the French production site, Flavelab at Beignon (Morbihan – France) specialising in the filling of injectable sterile powders.

2000

Acquisition of the German company Rotexmedica, with a manufacturing site for liquid injectables (near Hamburg) – Distribution extended to more than 100 countries (anglophone Africa, Middle East, South America).

1997

Construction of a new factory at Luitré (Ille-et-Vilaine – France)

1996

Distribution of products in more than 40 countries (Maghreb, francophone Africa, Middle East, South-East Asia) via a network of distributors.

1992

Appointment of Marie-Hélène Dick-Madelpuech as company chair of Panpharma

1988

A range of generic injectables (mainly antibiotics) is launched onto the French hospital market.

1983

Pierre-Richard Dick founds Panpharma and puts the first filling line of injectable sterile powders at Fougères (Ille-et-Vilaine – France) into operation.